RxDoctor Payments Data

Shane Napier, DO

Family Medicine · Beaver Dam, KYNPI 1457655730

Payments from drug & device makers

$381in general payments, 2019–2025

Across 21 payments — averaging $18.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$128
  • Medtronic$39
  • Pfizer$38
  • Lilly USA, LLC$29
  • Novo Nordisk$27
  • Sanofi-aventis U.S. LLC$22
  • plus $99 from 6 others

What the payments were for

  • Food & beverage$381100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$381 in reported general payments places this provider in the 35th percentile of 1,559 family medicine providers in Kentucky.

See all family medicine providers in Kentucky

Medicare billing

Part B allowed, 2024
$253,921
Medicare patients
575
Services billed
2,383

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate26$96,025
JardianceEmpagliflozin115$58,399
EliquisApixaban141$47,290
OzempicSemaglutide45$42,168
LinzessLinaclotide58$32,214
JanuviaSitagliptin Phosphate53$30,284
Trelegy ElliptaFluticasone/Umeclidin/Vilanter39$23,137
NuedextaDextromethorphan Hbr/Quinidine25$18,747
MounjaroTirzepatide14$14,223
MyrbetriqMirabegron40$12,476
FarxigaDapagliflozin Propanediol37$10,760
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen517$9,678
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog25$7,310
VascepaIcosapent Ethyl30$6,022
Breo ElliptaFluticasone/Vilanterol12$5,417

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$38$47,290141 claims
Novo NordiskOzempic$27$42,16845 claims
AbbVieLinzess$128$32,21458 claims
Avanir Pharmaceuticals, Inc.Nuedexta$19$18,74725 claims
Lilly USA, LLCMounjaro$29$14,22314 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 35th percentile of 1,559 family medicine providers in Kentucky.

Other family medicine in Beaver Dam

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →